Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients
Nutrition, Metabolism and Cardiovascular Diseases · 2025
DOI: 10.1016/j.numecd.2025.104535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Luc Heerkens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands. Electronic address: Luc.heerkens@wur.nl. Hauptthemen laut MEDLINE: Coronary Disease, Metabolomics, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jaap Schouten Foundation, Netherlands Heart Foundation, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND AND AIMS: We aimed to identify metabolite clusters and assess their relationships with prevalent steatotic liver disease (SLD) and fatal cardiovascular diseases (CVD) risk in coronary heart disease (CHD) patients. METHODS AND RESULTS: We included 6127 CHD patients from the UK Biobank (UKB; discovery cohort) and 877 from the Alpha Omega Cohort (AOC; validation cohort). Metabolites were quantified at baseline (UKB: 2006-2010; AOC: 2002-2006) using the Nightingale Health 1H NMR platform. We employed exploratory factor analysis to UKB metabolite data followed by confirmatory factor analysis in both cohorts. Prevalent SLD was defined as the upper sex-specific tertile of the Fatty Liver Index. Cause-specific mortality was monitored from baseline through November 30, 2022 for UKB and December 31, 2011 for AOC. Cox regression was used to derive prevalence ratios and hazard ratios with 95 % confidence intervals for prevalent SLD and fatal CVD risk, respectively. Seven metabolite clusters emerged, mainly consisting of VLDL lipoproteins, LDL, small HDL, large HDL, very small VLDL, amino acids, and a cluster with docosahexaenoic acid, glycine, and glutamine. The small HDL cluster was inversely associated with prevalent SLD (PRUKB:0.80 [0.69, 0.92]; PRAOC:0.39 [0.07, 2.09]) and fatal CVD risk (HRUKB:0.76 [0.62, 0.93]; HRAOC:0.67 [0.15, 2.97]). The very small VLDL cluster was positively associated with prevalent SLD (PRUKB:1.44 [1.37, 1.51]; PRAOC:1.84 [1.57, 2.16]) and fatal CVD risk (HRUKB:1.10 [1.03, 1.17]; HRAOC:1.12 [0.91, 1.38]). CONCLUSION: Small HDL and very small VLDL lipoproteins are likely involved in the biological pathways linking SLD to fatal CVD in CHD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands. Electronic address: Luc.heerkens@wur.nl.
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands.
- Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands. Electronic address: Franzel.vanduijnhoven@wur.nl.
Förderung
- Jaap Schouten Foundation
- Netherlands Heart Foundation
- National Institutes of Health
Zitieren
APA
Heerkens, L., Gonzales, G. B., Geleijnse, J. M., & van Duijnhoven, F. J. B. (2025). Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104535
Vancouver
Heerkens L, Gonzales GB, Geleijnse JM, van Duijnhoven FJB. Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104535
BibTeX
@article{Heerkens2025,
author = {Heerkens, Luc and Gonzales, Gerard Bryan and Geleijnse, Johanna M and van Duijnhoven, Fränzel J B},
title = {Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2025},
doi = {10.1016/j.numecd.2025.104535}
}
EUVIMED